RZLT
RZLT
NASDAQ · Biotechnology

Rezolute Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks
$3.84
-0.11 (-2.78%)
As of Sep 20, 10:34 PM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 13 81%
Hold 3 19%
Sell 0 0%
Price Target
Analyst Price Target +351.8% upside
Low Target $11.58
Average Target $17.35
High Target $20.59
Current Price $3.84
Current
$3.84
Target
$17.35
$11.58 $17.35 avg $20.59
Scenario Analysis
Bear Case
$11.58
201.6%
Low target
Base Case
$17.35
+351.8%
Avg target
Bull Case
$20.59
+436.2%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$11.46
-66.5% from high
52-Week Low
$1.07
+258.9% from low
Target vs 52W High
$17.35
+51.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -2.9%
AMGN
Amgen Inc
 Hold 43 47% $190.87 -53.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
 Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
 Hold 30 37% $149.45 -18.1%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -40.8%